HK1043943A1 - 肺炎链球菌蛋白质和疫苗 - Google Patents

肺炎链球菌蛋白质和疫苗 Download PDF

Info

Publication number
HK1043943A1
HK1043943A1 HK02105081.7A HK02105081A HK1043943A1 HK 1043943 A1 HK1043943 A1 HK 1043943A1 HK 02105081 A HK02105081 A HK 02105081A HK 1043943 A1 HK1043943 A1 HK 1043943A1
Authority
HK
Hong Kong
Prior art keywords
vaccines
streptococcus pneumoniae
pneumoniae proteins
polypeptides
relates
Prior art date
Application number
HK02105081.7A
Other languages
English (en)
Chinese (zh)
Inventor
E. Adamou John
H. Choi Gil
Original Assignee
Medimmune, Inc.
Human Genome Sciences, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medimmune, Inc., Human Genome Sciences, Inc. filed Critical Medimmune, Inc.
Publication of HK1043943A1 publication Critical patent/HK1043943A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1275—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Streptococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK02105081.7A 1999-06-10 2000-06-09 肺炎链球菌蛋白质和疫苗 HK1043943A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13845399P 1999-06-10 1999-06-10
US60/138,453 1999-06-10
PCT/US2000/015925 WO2000076540A2 (en) 1999-06-10 2000-06-09 Streptococcus pneumoniae proteins and vaccines

Publications (1)

Publication Number Publication Date
HK1043943A1 true HK1043943A1 (zh) 2002-10-04

Family

ID=22482080

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02105081.7A HK1043943A1 (zh) 1999-06-10 2000-06-09 肺炎链球菌蛋白质和疫苗

Country Status (9)

Country Link
EP (2) EP1185297B1 (enExample)
JP (1) JP2003501110A (enExample)
AT (2) ATE325620T1 (enExample)
AU (1) AU777856B2 (enExample)
CA (1) CA2371714C (enExample)
DE (2) DE60027890T2 (enExample)
ES (2) ES2264419T3 (enExample)
HK (1) HK1043943A1 (enExample)
WO (1) WO2000076540A2 (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7135560B1 (en) 1997-07-02 2006-11-14 Sanofi Pasteur Limited Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
US6800744B1 (en) 1997-07-02 2004-10-05 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
US7128918B1 (en) 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
US7074415B2 (en) 2000-06-20 2006-07-11 Id Biomedical Corporation Streptococcus antigens
GB0022742D0 (en) 2000-09-15 2000-11-01 Smithkline Beecham Biolog Vaccine
AU2002351623A1 (en) 2001-12-20 2003-07-09 Shire Biochem Inc. Streptococcus antigens
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
PL3017827T3 (pl) 2005-12-22 2019-04-30 Glaxosmithkline Biologicals Sa Szczepionka z koniugatem polisacharydu pneumokokowego
GB0607088D0 (en) 2006-04-07 2006-05-17 Glaxosmithkline Biolog Sa Vaccine
US9610339B2 (en) 2007-06-26 2017-04-04 Glaxosmithkline Biologicals, S.A. Vaccine comprising Streptococcus pneumoniae capsular polysaccharide conjugates
GB0714963D0 (en) 2007-08-01 2007-09-12 Novartis Ag Compositions comprising antigens
NZ586367A (en) 2007-12-13 2012-04-27 Intervacc Ab Improved immunizing composition comprising an antigen from Streptococcus equi
PL2268618T3 (pl) 2008-03-03 2015-11-30 Novartis Ag Związki i kompozycje jako modulatory aktywności receptorów TLR
PL2271360T3 (pl) 2008-04-16 2016-03-31 Glaxosmithkline Biologicals Sa Szczepionka
CN102762226A (zh) 2009-06-10 2012-10-31 诺华有限公司 含苯并萘啶的疫苗
MX2012000158A (es) 2009-06-29 2012-06-08 Genocea Biosciences Inc Vacunas y composiciones contra streptococcus pneumoniae.
JO3257B1 (ar) 2009-09-02 2018-09-16 Novartis Ag مركبات وتركيبات كمعدلات لفاعلية tlr
ES2443952T3 (es) 2009-09-02 2014-02-21 Novartis Ag Composiciones inmunógenas que incluyen moduladores de la actividad de TLR
US20120237536A1 (en) 2009-09-10 2012-09-20 Novartis Combination vaccines against respiratory tract diseases
WO2011057148A1 (en) 2009-11-05 2011-05-12 Irm Llc Compounds and compositions as tlr-7 activity modulators
US9408907B2 (en) 2009-12-15 2016-08-09 Glaxosmithkline Biologicals Sa Homogenous suspension of immunopotentiating compounds and uses thereof
GB201003924D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Immunogenic composition
JP5848748B2 (ja) 2010-03-23 2016-01-27 アイアールエム・リミテッド・ライアビリティ・カンパニーＩｒｍ，Ｌｌｃ 感染症、炎症、呼吸器疾患などの処置に使用するｔｌｒ２アゴニストとしての化合物（システインベースのリポペプチド）および組成物
WO2012072769A1 (en) 2010-12-01 2012-06-07 Novartis Ag Pneumococcal rrgb epitopes and clade combinations
CN105833260A (zh) 2011-01-20 2016-08-10 健诺西生物科学公司 针对肺炎链球菌（Streptococcus Pneumoniae）的疫苗和组合物
BR112013029514A2 (pt) 2011-05-17 2019-09-24 Glaxosmithkline Biologicals Sa composição imunogênica, vacina, e, método de tratar ou impedir uma doença
JP2015510872A (ja) 2012-03-07 2015-04-13 ノバルティス アーゲー Ｓｔｒｅｐｔｏｃｏｃｃｕｓｐｎｅｕｍｏｎｉａｅ抗原の増強された製剤
TR201807340T4 (tr) 2013-02-01 2018-06-21 Glaxosmithkline Biologicals Sa Çan benzeri reseptör agonistleri içeren immünolojik kompozisyonların intradermal yoldan verilmesi.
IL276608B2 (en) 2018-02-12 2024-04-01 Inimmune Corp Toll-like receptor ligands
JP2023547676A (ja) 2020-11-04 2023-11-13 エリゴ・バイオサイエンス ＤＮＡペイロードをアクネ菌集団へとｉｎ ｓｉｔｕ送達するためのファージ由来粒子

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998018931A2 (en) * 1996-10-31 1998-05-07 Human Genome Sciences, Inc. Streptococcus pneumoniae polynucleotides and sequences
EP1144640A3 (en) * 1998-07-27 2001-11-28 Microbial Technics Limited Nucleic acids and proteins from streptococcus pneumoniae

Also Published As

Publication number Publication date
DE60045721D1 (de) 2011-04-21
WO2000076540A3 (en) 2001-02-08
EP1731166A3 (en) 2007-02-21
DE60027890D1 (de) 2006-06-14
ES2264419T3 (es) 2007-01-01
EP1731166A2 (en) 2006-12-13
CA2371714C (en) 2012-12-04
EP1185297B1 (en) 2006-05-10
JP2003501110A (ja) 2003-01-14
EP1731166B1 (en) 2011-03-09
EP1185297A2 (en) 2002-03-13
WO2000076540A2 (en) 2000-12-21
ES2360296T3 (es) 2011-06-02
CA2371714A1 (en) 2000-12-21
DE60027890T2 (de) 2007-04-19
ATE500843T1 (de) 2011-03-15
AU5477800A (en) 2001-01-02
AU777856B2 (en) 2004-11-04
ATE325620T1 (de) 2006-06-15

Similar Documents

Publication Publication Date Title
HK1043943A1 (zh) 肺炎链球菌蛋白质和疫苗
WO2000056360A3 (en) Vaccine against antigens from bacteriae
WO2001098334A3 (en) Streptococcus antigens
WO2001081380A3 (en) Immunogenic pneumococcal protein and vaccine compositions thereof
WO2003054007A3 (en) Streptococcus antigens
WO2000039299A3 (en) Streptococcus antigens
WO1999042076A3 (en) Compounds and methods for immunotherapy and diagnosis of tuberculosis
WO1997009428A3 (en) Compounds and methods for immunotherapy and diagnosis of tuberculosis
WO2000062800A3 (en) Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide
WO1998016646A3 (en) Compounds and methods for immunotherapy and diagnosis of tuberculosis
WO1999042588A3 (en) Group b streptococcus antigens
WO2001058485A3 (en) Prophylactic and therapeutic antibodies against vaccina virus antigens
WO2000062801A3 (en) Combination vaccine against streptococcus pneumoniae and respiratory syncytial virus (rsv)
WO2006065553A3 (en) Glycoconjugate vaccines containing peptidoglycan
WO2002045742A8 (en) Lipoteichoic acid immunogenic compositions and methods of making and using thereof
WO2003065973A8 (en) Multivalent streptococcal vaccine compositions and methods for use
WO2000058475A3 (en) Streptococcus pneumoniae antigens
AU2001259217A1 (en) Human pellino polypeptides
WO2002028889A3 (en) Haemophilus influenzae antigens and corresponding dna fragments
WO2000055194A3 (en) Tuberculosis antigens and methods of use therefor
WO2000063386A3 (en) Prevention, diagnosis and treatment of lyme disease
WO2002066650A3 (en) Streptococcus pyogenes polypeptides and corresponding dna fragments
WO2002004497A3 (en) Multiple antigenic peptides immunogenic against streptococcus pneumoniae
WO2001040472A3 (en) Streptococcus pneumoniae antigens
WO2001066740A3 (en) Compositions and methods for the treatment of immune related diseases